190 related articles for article (PubMed ID: 25341731)
1. Interleukin 1 receptor-associated kinase 1 (IRAK1) mutation is a common, essential driver for Kaposi sarcoma herpesvirus lymphoma.
Yang D; Chen W; Xiong J; Sherrod CJ; Henry DH; Dittmer DP
Proc Natl Acad Sci U S A; 2014 Nov; 111(44):E4762-8. PubMed ID: 25341731
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 Receptor-Associated Kinase (IRAK) Signaling in Kaposi Sarcoma-Associated Herpesvirus-Induced Primary Effusion Lymphoma.
Seltzer J; Moorad R; Schifano JM; Landis JT; Dittmer DP
J Virol; 2020 May; 94(10):. PubMed ID: 32161170
[TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus microRNAs target IRAK1 and MYD88, two components of the toll-like receptor/interleukin-1R signaling cascade, to reduce inflammatory-cytokine expression.
Abend JR; Ramalingam D; Kieffer-Kwon P; Uldrick TS; Yarchoan R; Ziegelbauer JM
J Virol; 2012 Nov; 86(21):11663-74. PubMed ID: 22896623
[TBL] [Abstract][Full Text] [Related]
4. Novel approaches to targeting MYD88 in Waldenström macroglobulinemia.
Castillo JJ; Hunter ZR; Yang G; Treon SP
Expert Rev Hematol; 2017 Aug; 10(8):739-744. PubMed ID: 28617062
[TBL] [Abstract][Full Text] [Related]
5. Primary effusion lymphoma presenting as a cutaneous intravascular lymphoma.
Crane GM; Xian RR; Burns KH; Borowitz MJ; Duffield AS; Taube JM
J Cutan Pathol; 2014 Dec; 41(12):928-35. PubMed ID: 25355615
[TBL] [Abstract][Full Text] [Related]
6. High levels of LINE-1 transposable elements expressed in Kaposi's sarcoma-associated herpesvirus-related primary effusion lymphoma.
Ahuja A; Journo G; Eitan R; Rubin E; Shamay M
Oncogene; 2021 Jan; 40(3):536-550. PubMed ID: 33188297
[TBL] [Abstract][Full Text] [Related]
7. Establishment and characterization of a novel VEGF-producing HHV-8-unrelated PEL-like lymphoma cell line, OGU1.
Kawauchi K; Ogasawara T; Aiba M; Fujibayashi M; Sanaka T; Sakura H; Shibuya M
Eur J Haematol; 2016 Feb; 96(2):144-51. PubMed ID: 25846106
[TBL] [Abstract][Full Text] [Related]
8. Diethyldithiocarbamate induces apoptosis in HHV-8-infected primary effusion lymphoma cells via inhibition of the NF-κB pathway.
Matsuno T; Kariya R; Yano S; Morino-Koga S; Taura M; Suico MA; Shimauchi Y; Matsuyama S; Okamoto Y; Shuto T; Kai H; Okada S
Int J Oncol; 2012 Apr; 40(4):1071-8. PubMed ID: 22200846
[TBL] [Abstract][Full Text] [Related]
9. A mutation in MYD88 (L265P) supports the survival of lymphoplasmacytic cells by activation of Bruton tyrosine kinase in Waldenström macroglobulinemia.
Yang G; Zhou Y; Liu X; Xu L; Cao Y; Manning RJ; Patterson CJ; Buhrlage SJ; Gray N; Tai YT; Anderson KC; Hunter ZR; Treon SP
Blood; 2013 Aug; 122(7):1222-32. PubMed ID: 23836557
[TBL] [Abstract][Full Text] [Related]
10. Extracavitary KSHV-associated large B-Cell lymphoma: a distinct entity or a subtype of primary effusion lymphoma? Study of 9 cases and review of an additional 43 cases.
Pan ZG; Zhang QY; Lu ZB; Quinto T; Rozenvald IB; Liu LT; Wilson D; Reddy V; Huang Q; Wang HY; Ren YS
Am J Surg Pathol; 2012 Aug; 36(8):1129-40. PubMed ID: 22790853
[TBL] [Abstract][Full Text] [Related]
11. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
12. FADD negatively regulates lipopolysaccharide signaling by impairing interleukin-1 receptor-associated kinase 1-MyD88 interaction.
Zhande R; Dauphinee SM; Thomas JA; Yamamoto M; Akira S; Karsan A
Mol Cell Biol; 2007 Nov; 27(21):7394-404. PubMed ID: 17785432
[TBL] [Abstract][Full Text] [Related]
13. Targeting Myddosome Signaling in Waldenström's Macroglobulinemia with the Interleukin-1 Receptor-Associated Kinase 1/4 Inhibitor R191.
Ni H; Shirazi F; Baladandayuthapani V; Lin H; Kuiatse I; Wang H; Jones RJ; Berkova Z; Hitoshi Y; Ansell SM; Treon SP; Thomas SK; Lee HC; Wang Z; Davis RE; Orlowski RZ
Clin Cancer Res; 2018 Dec; 24(24):6408-6420. PubMed ID: 30126942
[TBL] [Abstract][Full Text] [Related]
14. Primary effusion lymphoma: genomic profiling revealed amplification of SELPLG and CORO1C encoding for proteins important for cell migration.
Luan SL; Boulanger E; Ye H; Chanudet E; Johnson N; Hamoudi RA; Bacon CM; Liu H; Huang Y; Said J; Chu P; Clemen CS; Cesarman E; Chadburn A; Isaacson PG; Du MQ
J Pathol; 2010 Oct; 222(2):166-79. PubMed ID: 20690162
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of activating c-MET in KSHV+ primary effusion lymphoma.
Lam BQ; Dai L; Li L; Qiao J; Lin Z; Qin Z
Oncotarget; 2017 Mar; 8(11):18373-18380. PubMed ID: 28407694
[TBL] [Abstract][Full Text] [Related]
16. KHSV(-) EBV(-) post-transplant effusion lymphoma with plasmablastic features: variant of primary effusion lymphoma?
Lambe JS; Oble DA; Nandula SV; Sevilla DW; Colovai AI; Mansukhani M; Chari A; Murty VV; Alobeid B; Bhagat G
Hematol Oncol; 2009 Dec; 27(4):203-10. PubMed ID: 19337983
[TBL] [Abstract][Full Text] [Related]
17. Multiple viral infections in primary effusion lymphoma: a model of viral cooperation in lymphomagenesis.
Gloghini A; Volpi CC; Gualeni AV; Dolcetti R; Bongarzone I; De Paoli P; Carbone A
Expert Rev Hematol; 2017 Jun; 10(6):505-514. PubMed ID: 28468596
[TBL] [Abstract][Full Text] [Related]
18. Genotypic and clinicopathological characterization of Kaposi's sarcoma-associated herpesvirus infection in Japan.
Kanno T; Sato Y; Nakamura T; Sakamoto K; Sata T; Katano H
J Med Virol; 2010 Mar; 82(3):400-6. PubMed ID: 20087946
[TBL] [Abstract][Full Text] [Related]
19. Sangivamycin induces apoptosis by suppressing Erk signaling in primary effusion lymphoma cells.
Wakao K; Watanabe T; Takadama T; Ui S; Shigemi Z; Kagawa H; Higashi C; Ohga R; Taira T; Fujimuro M
Biochem Biophys Res Commun; 2014 Feb; 444(2):135-40. PubMed ID: 24434142
[TBL] [Abstract][Full Text] [Related]
20. Kaposi sarcoma herpesvirus/human herpesvirus-8-negative effusion-based lymphoma: report of 3 cases and review of the literature.
Xiao J; Selvaggi SM; Leith CP; Fitzgerald SA; Stewart J
Cancer Cytopathol; 2013 Nov; 121(11):661-9. PubMed ID: 23765802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
